1 - 25 of
27
results
for author:"Fernandes C."
in Literature Citations
| Crystal structure of a phospholipase A(2) homolog complexed with p-bromophenacyl bromide reveals important structural changes associated with the inhibition of myotoxic activity. Marchi-Salvador D.P., Fernandes C.A., Silveira L.B., Soares A.M., Fontes M.R. Biochim. Biophys. Acta 1794:1583-1590(2009) · Mapped (1) |
| Striatum is more vulnerable to oxidative damage induced by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency as compared to liver. Leipnitz G., Seminotti B., Fernandes C.G., Amaral A.U., Beskow A.P., da Silva L.d.e. B., Zanatta A., Ribeiro C.A., Vargas C.R., Wajner M. Int. J. Dev. Neurosci. 27:351-356(2009) · Mapped (1) |
| A unique combination of genetic systems for the synthesis of trehalose in Rubrobacter xylanophilus: properties of a rare actinobacterial TreT. Nobre A., Alarico S., Fernandes C., Empadinhas N., da Costa M.S. J. Bacteriol. 190:7939-7946(2008) · UniProtKB (7) |
| Cloning and molecular characterization of the orphan carrier protein Slc10a4: expression in cholinergic neurons of the rat central nervous system. Geyer J., Fernandes C.F., Doring B., Burger S., Godoy J.R., Rafalzik S., Hubschle T., Gerstberger R., Petzinger E. Neuroscience 152:990-1005(2008) · Mapped (1) |
| Gene expression profiling reveals upregulation of Tlr4 receptors in Cckb receptor deficient mice. Koks S., Fernandes C., Kurrikoff K., Vasar E., Schalkwyk L.C. Behav. Brain Res. 188:62-70(2008) · Mapped (4) |
| The novel putative bile acid transporter SLC10A5 is highly expressed in liver and kidney. Fernandes C.F., Godoy J.R., Doring B., Cavalcanti M.C., Bergmann M., Petzinger E., Geyer J. Biochem. Biophys. Res. Commun. 361:26-32(2007) · Mapped (4) |
| Molecular and phylogenetic characterization of a novel putative membrane transporter (SLC10A7), conserved in vertebrates and bacteria. Godoy J.R., Fernandes C., Doring B., Beuerlein K., Petzinger E., Geyer J. Eur. J. Cell Biol. 86:445-460(2007) · UniProtKB (1) · Mapped (7) |
| Quantitative traits for the tail suspension test: automation, optimization, and BXD RI mapping. Lad H.V., Liu L., Paya-Cano J.L., Fernandes C., Schalkwyk L.C. Mamm. Genome 18:482-491(2007) · Mapped (31) |
| Bifunctional CTP:inositol-1-phosphate cytidylyltransferase/CDP-inositol:inositol-1-phosphate transferase, the key enzyme for di-myo-inositol-phosphate synthesis in several (hyper)thermophiles. Rodrigues M.V., Borges N., Henriques M., Lamosa P., Ventura R., Fernandes C., Empadinhas N., Maycock C., da Costa M.S., Santos H. J. Bacteriol. 189:5405-5412(2007) · UniProtKB (1) |
| Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6). Geyer J., Doering B., Meerkamp K., Ugele B., Bakhiya N., Fernandes C.F., Godoy J.R., Glatt H., Petzinger E. J. Biol. Chem. 282:19728-19741(2007) · UniProtKB (1) |
| Single-step pathway for synthesis of glucosylglycerate in Persephonella marina. Fernandes C., Empadinhas N., da Costa M.S. J. Bacteriol. 189:4014-4019(2007) · UniProtKB (2) |
| Interpretation of knockout experiments: the congenic footprint. Schalkwyk L.C., Fernandes C., Nash M.W., Kurrikoff K., Vasar E., Koks S. Genes Brain Behav. 6:299-303(2007) · Mapped (4) |
| The ongoing adaptive evolution of ASPM and Microcephalin is not explained by increased intelligence. Mekel-Bobrov N., Posthuma D., Gilbert S.L., Lind P., Gosso M.F., Luciano M., Harris S.E., Bates T.C., Polderman T.J., Whalley L.J. et al. Hum. Mol. Genet. 16:600-608(2007) · Mapped (43) |
| High hydrostatic pressure activates gene expression through Msn2/4 stress transcription factors which are involved in the acquired tolerance by mild pressure precondition in Saccharomyces cerevisiae. Domitrovic T., Fernandes C.M., Boy-Marcotte E., Kurtenbach E. FEBS Lett. 580:6033-6038(2006) · Mapped (3) |
| The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. McLeod M.P., Warren R.L., Hsiao W.W.L., Araki N., Myhre M., Fernandes C., Miyazawa D., Wong W., Lillquist A.L., Wang D. et al. Proc. Natl. Acad. Sci. U.S.A. 103:15582-15587(2006) · UniProtKB (9,075) |
| Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Hoyle E., Genn R.F., Fernandes C., Stolerman I.P. Psychopharmacology (Berl.) 189:211-223(2006) · Mapped (5) |
| Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Fernandes C., Hoyle E., Dempster E., Schalkwyk L.C., Collier D.A. Genes Brain Behav. 5:433-440(2006) · Mapped (5) |
| RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure. Carleton M., Mao M., Biery M., Warrener P., Kim S., Buser C., Marshall C.G., Fernandes C., Annis J., Linsley P.S. Mol. Cell. Biol. 26:3853-3863(2006) · UniProtKB (1) |
| Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP. Fraley M.E., Garbaccio R.M., Arrington K.L., Hoffman W.F., Tasber E.S., Coleman P.J., Buser C.A., Walsh E.S., Hamilton K., Fernandes C. et al. Bioorg. Med. Chem. Lett. 16:1775-1779(2006) · Mapped (1) |
| Tolerance to nicotine in mice lacking alpha7 nicotinic receptors. Naylor C., Quarta D., Fernandes C., Stolerman I.P. Psychopharmacology (Berl.) 180:558-563(2005) · Mapped (5) |
| Physical and functional interaction between Pes1 and Bop1 in mammalian ribosome biogenesis. Lapik Y.R., Fernandes C.J., Lau L.F., Pestov D.G. |
| Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. Diogenes M.J., Fernandes C.C., Sebastiao A.M., Ribeiro J.A. J. Neurosci. 24:2905-2913(2004) · Mapped (4) |
| The role of nicotinic receptor alpha 7 subunits in nicotine discrimination. Stolerman I.P., Chamberlain S., Bizarro L., Fernandes C., Schalkwyk L. Neuropharmacology 46:363-371(2004) · Mapped (5) |
| Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents. deSolms S.J., Ciccarone T.M., MacTough S.C., Shaw A.W., Buser C.A., Ellis-Hutchings M., Fernandes C., Hamilton K.A., Huber H.E., Kohl N.E. et al. J. Med. Chem. 46:2973-2984(2003) · UniProtKB (2) |
| 3-aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency. Bell I.M., Gallicchio S.N., Abrams M., Beese L.S., Beshore D.C., Bhimnathwala H., Bogusky M.J., Buser C.A., Culberson J.C., Davide J. et al. J. Med. Chem. 45:2388-2409(2002) · UniProtKB (2) · Mapped (1) |
